Advancing AI in Cardiovascular Care
Apollo Hospitals, one of India’s largest healthcare providers, has announced a new partnership to enhance its AI-driven Cardiovascular Disease Risk tool. It will collaborate with Solventum Health Information Systems, a spinoff of 3M, to integrate patient classification and quality methodologies into its predictive analytics system.
Enhancing Predictive Capabilities
Solventum’s tools will complement Apollo’s AI-powered technology, improving its ability to assess cardiovascular risk. Together, they aim to measure the effectiveness of their combined solution using key population health and resource efficiency metrics, such as mortality rates, hospital stays, complications, and readmissions.
According to their joint media release, this initiative seeks to deliver high-quality care in a cost-effective manner. It will leverage diagnosis-related groups, case mix index, and severity of illness while optimizing resource utilization.
Addressing a Critical Healthcare Challenge
Cardiovascular diseases remain the leading cause of premature death and morbidity in India, responsible for over a quarter of all deaths. With only one cardiologist available per 250,000 people, predictive analytics can help bridge this healthcare gap.
By enhancing Apollo’s AI tool, the partnership will enable better identification of high-risk patients, reducing adverse outcomes and the need for hospitalizations.
Apollo’s Ongoing AI Initiatives
As reported by healthcareitnews, Apollo launched its Cardiovascular Disease Risk tool in 2021, leveraging data from over 400,000 patients to predict cardiovascular risks based on lifestyle factors and vital signs. In 2022, the tool was integrated into ConnectedLife, a Singapore-based healthcare application partnered with Fitbit.
Beyond cardiovascular analytics, Apollo has pursued various AI-driven projects. Recently, it announced plans to adopt AI copilots from Microsoft to accelerate its AI roadmap.
Expert Insights on the Collaboration
Dr. Sangita Reddy, Co-Managing Director of Apollo Hospitals, emphasized the impact of this partnership. She stated, “This collaboration allows us to identify high-risk patients more accurately and provide timely, personalized care.” It is reducing complications and hospital stays while transforming patient outcomes and expanding access to high-quality healthcare.”
Dr. Sandeep Wadhwa, Global Chief Medical Officer at Solventum HIS, added, “We anticipate improved patient access. Our joint efforts will also enhance operational efficiency and clinical outcomes.” Our collaboration will help identify patients at high risk and provide additional services as needed.”